SS.LEW-(D17Rat65-D17Chm2)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.9 |
mg/g |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64904 |
226 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.7 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64906 |
226 |
SS.LEW-(D16Rat38-D16Chm66)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
3.3 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64912 |
226 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
2.97 |
mg/g |
0.08 |
0.23 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64914 |
226 |
SHR/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
male |
84 days
| 14 |
|
2.68 |
mg/g |
0.19 |
0.71 |
post excision weight measurement |
|
|
|
0 |
|
|
|
13050 |
327 |
DRY |
heart left ventricle weight to body weight ratio |
control condition |
Innes BA, et al., Hypertension 1998 Mar;31(3):741-6 |
heart left ventricle mass |
male |
140 days
| 35 |
|
1.82 |
mg/g |
0.01 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
11667 |
113 |
BN.GH-(D6Mit12-D6Rat15)/Mcwi |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
16 |
|
3.8 |
mg/g |
0.08 |
0.3 |
post excision weight measurement |
|
0.0 |
|
0 |
|
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68336 |
101 |
BN/Elh |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
|
3.7 |
mg/g |
0.13 |
0.6 |
post excision weight measurement |
|
0.0 |
|
0 |
|
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68338 |
101 |
COP.DA-(D16Rat12-D16Rat90)/Mco |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105 days
| 8 |
|
1.75 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68519 |
933 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
720 |
min |
|
|
98787 |
2160 |
SHRSP.WKY-(D3Mgh16-rs197649383)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
3.57 |
mg/g |
0.66 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102116 |
2646 |
LH/Mav |
heart left ventricle weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 6 |
|
2.88 |
mg/g |
0.06 |
0.15 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103412 |
2824 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 14 |
|
2.25 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102769 |
2721 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.8 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
2 |
days |
|
|
98876 |
2160 |
GK/MolTac |
heart left ventricle weight to body weight ratio |
control condition |
Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricle mass |
male |
112 days
| 8 |
|
3.41 |
mg/g |
0.17 |
0.48 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
102990 |
2783 |
Hsd:WI |
heart left ventricle weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
heart left ventricle mass |
male |
100 days
| 16 |
|
1.67 |
mg/g |
0.04 |
0.16 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
108099 |
3115 |
SHR/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168 days
| 10 |
|
2.51 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108940 |
3133 |
SS.LEW-(D18Rat30-D18Chm29)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
2.9 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64884 |
226 |
SS.LEW-(D8Chm14-D8Rat16)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 7 |
|
2.57 |
mg/g |
0.05 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64933 |
226 |
LH/Mav |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 11 |
|
2.24 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102768 |
2721 |
SHR/N |
heart left ventricle weight to body weight ratio |
control condition |
Innes BA, et al., Hypertension 1998 Mar;31(3):741-6 |
heart left ventricle mass |
male |
140 days
| 34 |
|
2.83 |
mg/g |
0.02 |
0.12 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
66121 |
113 |
LEW |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 6 |
|
1.87 |
mg/g |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64890 |
226 |
SS.LEW-(D16Got3-D16Rat112)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
2.86 |
mg/g |
0.06 |
0.18 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64908 |
226 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 7 |
|
2.72 |
mg/g |
0.04 |
0.11 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64916 |
226 |
SS.LEW-(D3Rat61-D3Wox1)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.33 |
mg/g |
0.04 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64939 |
226 |
GH/Omr |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
|
4.7 |
mg/g |
0.15 |
0.7 |
post excision weight measurement |
|
0.0 |
|
0 |
|
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68334 |
101 |
BN.GH-(D2Rat22-D2Mgh11)/Mcwi |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
19 |
|
3.4 |
mg/g |
0.11 |
0.5 |
post excision weight measurement |
|
0.0 |
|
0 |
|
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68335 |
101 |
SS/Jr |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 40 |
|
2.99 |
mg/g |
0.06 |
0.38 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68258 |
542 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 18 |
|
2.85 |
mg/g |
0.55 |
2.35 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68261 |
542 |
COP/OlaHsd |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105 days
| 15 |
|
1.75 |
mg/g |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68517 |
933 |
SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 7 |
|
3.0 |
mg/g |
0.11 |
0.29 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102114 |
2646 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
360 |
min |
|
|
98786 |
2160 |
LH/Mav |
heart left ventricle weight to body weight ratio |
controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 7 |
|
2.48 |
mg/g |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103409 |
2824 |
GK |
heart left ventricle weight to body weight ratio |
controlled air oxygen content (5 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart left ventricle mass |
male |
16 days
| 7 |
|
2.15 |
mg/g |
0.16 |
0.42 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103010 |
2784 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
98 days
| 8 |
|
3.1 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
|
0.0 |
ACF |
28 |
days |
|
|
99204 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
175 days
| 10 |
|
3.1 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
|
0.0 |
ACF |
105 |
days |
|
|
99206 |
2278 |
WI |
heart left ventricle weight to body weight ratio |
swimming (for 0.2 hours) |
Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28. |
heart left ventricle mass |
female |
0 days
| 16 |
|
2.1 |
mg/g |
0.02 |
0.09 |
post excision weight measurement |
|
1.0 |
|
0 |
|
following 8 wk protocol |
|
98752 |
2159 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
9 |
|
3.06 |
mg/g |
0.07 |
0.21 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107038 |
3073 |
MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168 days
| 10 |
|
1.86 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108944 |
3133 |
MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168 days
| 10 |
|
2.42 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108945 |
3133 |
WKY/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
male |
84 days
| 15 |
|
1.99 |
mg/g |
0.08 |
0.31 |
post excision weight measurement |
|
|
|
0 |
|
|
|
13066 |
327 |
SS/JrHsdMcwi |
heart left ventricle weight to body weight ratio |
monocrotaline (40 mg/kg) |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart left ventricle mass |
male |
56 days
| 11 |
|
2.86 |
mg/g |
0.1 |
0.33 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106588 |
3032 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
720 |
min |
|
|
98788 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (between 120 and 12 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
5 |
days |
|
|
98792 |
2160 |
LH/MavRrrc |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 8 |
|
23.0 |
mg/g |
0.2 |
0.57 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102681 |
2703 |
SS.LEW-(D18Rat61-D18Rat45)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 6 |
|
2.61 |
mg/g |
0.08 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64900 |
226 |
SHR/Izm |
heart left ventricle weight to body weight ratio |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
heart left ventricle mass |
male |
168 days
| 6 |
|
2.7 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
polyethylene catheter (PE-50) |
|
67219 |
103 |
SS.MNS-(D2Chm25-Fgg)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
2.94 |
mg/g |
0.08 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64950 |
226 |
SS.MNS-(D2Chm25-D2Rat131)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.85 |
mg/g |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64958 |
226 |
SS.MNS-(D2Rat183-D2Chm113)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
2.76 |
mg/g |
0.07 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64960 |
226 |
SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
3.04 |
mg/g |
0.29 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102111 |
2646 |
SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
2.79 |
mg/g |
0.14 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102113 |
2646 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
2 |
days |
|
|
98789 |
2160 |
LH/Mav |
heart left ventricle weight to body weight ratio |
perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 8 |
|
2.41 |
mg/g |
0.08 |
0.23 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103410 |
2824 |
LH/Mav |
heart left ventricle weight to body weight ratio |
perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 8 |
|
2.37 |
mg/g |
0.07 |
0.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103411 |
2824 |
Jcl:WI |
heart left ventricle weight to body weight ratio |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
1.85 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103067 |
2785 |
GK/Jcl |
heart left ventricle weight to body weight ratio |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
1.95 |
mg/g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103069 |
2785 |
SR/NEisSlc |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
heart left ventricle mass |
male |
77 days
| 10 |
|
2.33 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102488 |
2690 |
LL/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (100 mg/kg) |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 18 |
|
1.93 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102767 |
2721 |
Crlj:WI |
heart left ventricle weight to body weight ratio |
controlled air oxygen content (21 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart left ventricle mass |
male |
16 days
| 6 |
|
1.75 |
mg/g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103007 |
2784 |
Crlj:WI |
heart left ventricle weight to body weight ratio |
controlled air oxygen content (5 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart left ventricle mass |
male |
16 days
| 7 |
|
1.74 |
mg/g |
0.11 |
0.29 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103008 |
2784 |
SD-Tg(Ren2)27 |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 6 |
|
2.88 |
mg/g |
0.11 |
0.27 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103481 |
2826 |
WKY |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 5 |
|
2.29 |
mg/g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103482 |
2826 |
LL/Mav |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 5 |
|
2.0 |
mg/g |
0.02 |
0.04 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103484 |
2826 |
LL/Mav |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 13 |
|
20.4 |
mg/g |
0.1 |
0.36 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102680 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 8 |
|
24.4 |
mg/g |
0.4 |
1.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102682 |
2703 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then hydralazine (75 mg/kg/d) (for 56 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 56 days) and reserpine (0.75 ml/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 7 |
|
24.2 |
mg/g |
0.3 |
0.79 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102685 |
2703 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
98 days
| 8 |
|
2.1 |
mg/g |
0.1 |
0.28 |
post excision weight measurement |
|
0.0 |
sham ACF |
28 |
days |
|
|
99203 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart left ventricle mass |
male |
175 days
| 10 |
|
1.9 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
|
0.0 |
sham ACF |
105 |
days |
|
|
99205 |
2278 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
189 days
| 6 |
|
1.44 |
mg/g |
0.02 |
0.05 |
ex vivo method |
|
0.0 |
sham lad occlusion |
140 |
days |
|
|
101098 |
2564 |
SS/JrHsdMcwi |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart left ventricle mass |
male |
56 days
| 7 |
|
2.43 |
mg/g |
0.05 |
0.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106586 |
3032 |
SS-Sod3m1Mcwi |
heart left ventricle weight to body weight ratio |
monocrotaline (40 mg/kg) |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart left ventricle mass |
male |
56 days
| 15 |
|
2.76 |
mg/g |
0.05 |
0.19 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106589 |
3032 |
MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
heart left ventricle mass |
male |
100 days
| 10 |
|
1.91 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
108100 |
3115 |
SHR/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168 days
| 10 |
|
3.02 |
mg/g |
0.07 |
0.22 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108941 |
3133 |
SS.MNS-(D2Chm51-D2Rat341)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
3.0 |
mg/g |
0.2 |
0.57 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64954 |
226 |
SS.LEW-(D2Rat199-D2Mco17)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
3.44 |
mg/g |
0.07 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64962 |
226 |
LEW/CrlCrlj |
heart left ventricle weight to body weight ratio |
control condition |
Tsujita Y, et al., Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2062-7 |
heart left ventricle mass |
male |
168 days
| 5 |
|
1.67 |
mg/g |
0.02 |
0.04 |
post excision weight measurement |
|
|
|
0 |
|
polyethylene catheter (PE-50) |
|
67218 |
103 |
SS.LEW-(D10Rat27-Igfbp4)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 7 |
|
3.0 |
mg/g |
0.1 |
0.26 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64922 |
226 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 5 |
|
2.51 |
mg/g |
0.16 |
0.35 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68263 |
542 |
WI |
heart left ventricle weight to body weight ratio |
swimming with water weights (for 1 hours) |
Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28. |
heart left ventricle mass |
female |
0 days
| 16 |
|
2.7 |
mg/g |
0.03 |
0.13 |
post excision weight measurement |
|
1.0 |
swim |
1 |
days |
following 8 wk protocol |
|
98751 |
2159 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 6 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
360 |
min |
|
|
98785 |
2160 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (1 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 11 |
|
19.9 |
mg/g |
0.5 |
1.66 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102684 |
2703 |
SD-Tg(Ren2)27-/- |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 6 |
|
2.25 |
mg/g |
0.02 |
0.05 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103480 |
2826 |
SS.LEW-(D10Chm224-D10Chm6)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 11 |
|
2.78 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64886 |
226 |
SS.LEW-(D18Chm91-D18Rat67)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.7 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64896 |
226 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
2.42 |
mg/g |
0.04 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64898 |
226 |
SS.LEW-(D3Rat52-D3Rat130)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 7 |
|
2.67 |
mg/g |
0.09 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64948 |
226 |
F344/NHsd |
heart left ventricle weight to body weight ratio |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
heart left ventricle mass |
not specified |
84 days
| 23 |
|
2.1 |
mg/g |
0.02 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
12179 |
233 |
WKY/NCruk |
heart left ventricle weight to body weight ratio |
control condition |
Sebkhi A, et al., Hypertension 1999 Apr;33(4):949-53. |
heart left ventricle mass |
not specified |
84 days
| 22 |
|
2.53 |
mg/g |
0.03 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
12185 |
233 |
COP.DA-(D3Rat233-D3Mgh14)/Mco |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105 days
| 18 |
|
1.96 |
mg/g |
0.05 |
0.21 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68520 |
933 |
WKY/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
2.52 |
mg/g |
0.2 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102110 |
2646 |
SHRSP.WKY-(D3Mgh16-D3Mit10)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
3.28 |
mg/g |
0.19 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102117 |
2646 |
SS/NEisSlc |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
heart left ventricle mass |
male |
77 days
| 10 |
|
3.35 |
mg/g |
0.12 |
0.38 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102490 |
2690 |
SS/NEisSlc |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
heart left ventricle mass |
male |
126 days
| 10 |
|
4.39 |
mg/g |
0.08 |
0.24 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102491 |
2690 |
LL/Mav |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. |
heart left ventricle mass |
male |
112 days
| 9 |
|
1.88 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102766 |
2721 |
Jcl:WI |
heart left ventricle weight to body weight ratio |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
1.82 |
mg/g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103068 |
2785 |
LH/Mav |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 5 |
|
2.43 |
mg/g |
0.08 |
0.18 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103485 |
2826 |
GK |
heart left ventricle weight to body weight ratio |
controlled air oxygen content (21 %) (for 28 days) |
Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. |
heart left ventricle mass |
male |
16 days
| 5 |
|
2.11 |
mg/g |
0.06 |
0.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103009 |
2784 |
Crl:WI |
heart left ventricle weight to body weight ratio |
control condition |
Korkmaz-Ic?z S, et al., Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H958-H971. doi: 10.1152/ajpheart.00956.2015. Epub 2016 Aug 12. |
heart left ventricle mass |
male |
112 days
| 10 |
|
2.52 |
mg/g |
0.17 |
0.54 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
102989 |
2783 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
2 |
days |
|
|
98874 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
77 days
| 6 |
|
1.56 |
mg/g |
0.03 |
0.07 |
ex vivo method |
|
0.0 |
sham lad occlusion |
28 |
days |
|
|
101096 |
2564 |
SD |
heart left ventricle weight to body weight ratio |
left anterior descending coronary artery occlusion (for 140 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
189 days
| 10 |
|
1.53 |
mg/g |
0.04 |
0.13 |
ex vivo method |
|
0.0 |
lad occlusion |
140 |
days |
|
|
101097 |
2564 |
SS-Sod3m1Mcwi |
heart left ventricle weight to body weight ratio |
vehicle control condition |
Xu D, et al., Hypertension. 2011 Aug;58(2):303-9. doi: 10.1161/HYPERTENSIONAHA.110.166819. Epub 2011 Jul 5. |
heart left ventricle mass |
male |
56 days
| 10 |
|
2.49 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
106587 |
3032 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
8 |
|
2.68 |
mg/g |
0.03 |
0.08 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107034 |
3073 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (0.1 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
6 |
|
2.69 |
mg/g |
0.08 |
0.2 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107036 |
3073 |
SS.LEW-(D10Chm128-D10Chm121)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
2.9 |
mg/g |
0.2 |
0.6 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64918 |
226 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
3.1 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64956 |
226 |
SS.LEW-(D2Rat18-D2Chm277)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 6 |
|
3.6 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64964 |
226 |
SHR/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
female |
84 days
| 16 |
|
2.38 |
mg/g |
0.2 |
0.8 |
post excision weight measurement |
|
|
|
0 |
|
|
|
13058 |
327 |
SS.LEW-(D17Chm9-D17Rat97)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
3.3 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64902 |
226 |
SS.LEW-(D16Rat12-D16Chm23)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
3.54 |
mg/g |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64910 |
226 |
SS.LEW-(D3Got33-D3Chm68)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
2.99 |
mg/g |
0.08 |
0.25 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64944 |
226 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 8 |
|
2.81 |
mg/g |
0.05 |
0.14 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68260 |
542 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.3 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
2 |
days |
|
|
98875 |
2160 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.5 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
2 |
days |
|
|
98877 |
2160 |
SHR |
heart left ventricle weight to body weight ratio |
control condition (for 0 hours) |
Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. |
heart left ventricle mass |
male |
84 days
| 5 |
|
2.71 |
mg/g |
0.11 |
0.25 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103483 |
2826 |
SS/Jr |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 16 |
|
3.41 |
mg/g |
0.09 |
0.36 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64892 |
226 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
4.0 |
mg/g |
0.3 |
0.9 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64929 |
226 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 11 |
|
2.75 |
mg/g |
0.11 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68259 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 14 |
|
2.67 |
mg/g |
0.08 |
0.31 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68262 |
542 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 8 |
|
2.69 |
mg/g |
0.09 |
0.26 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68264 |
542 |
DA/OlaHsd |
heart left ventricle weight to body weight ratio |
control condition |
Ways JA, et al., Physiol Genomics. 2006 Dec 19;. |
heart left ventricle mass |
not specified |
105 days
| 12 |
|
2.13 |
mg/g |
0.04 |
0.14 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68518 |
933 |
SD |
heart left ventricle weight to body weight ratio |
artificial aortocaval fistula (for 5 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.7 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
ACF |
5 |
days |
|
|
98791 |
2160 |
SHRSP/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
3.64 |
mg/g |
0.39 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102109 |
2646 |
SHRSP.WKY-(D3Wox20-D3Rat114)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 6 |
|
3.33 |
mg/g |
0.33 |
0.81 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102112 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
|
3.12 |
mg/g |
0.24 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102115 |
2646 |
GK/Jcl |
heart left ventricle weight to body weight ratio |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
heart left ventricle mass |
male |
84 days
| 8 |
|
1.98 |
mg/g |
0.03 |
0.08 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103070 |
2785 |
SR/NEisSlc |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
heart left ventricle mass |
male |
126 days
| 10 |
|
1.95 |
mg/g |
0.03 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102489 |
2690 |
Crl:WI |
heart left ventricle weight to body weight ratio |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle mass |
male |
168 days
| 4 |
|
2.45 |
mg/g |
0.16 |
0.31 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
103113 |
2786 |
LH/Mav |
heart left ventricle weight to body weight ratio |
streptozotocin (75 mg/kg) then perindopril (0.01 mg/kg/d) (for 56 days) |
Emonnot L, et al., Am J Hypertens. 2008 Jun;21(6):657-62. doi: 10.1038/ajh.2008.155. Epub 2008 Apr 3. |
heart left ventricle mass |
male |
112 days
| 9 |
|
23.8 |
mg/g |
0.8 |
2.4 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
102683 |
2703 |
GK/CskCrljCrl |
heart left ventricle weight to body weight ratio |
control condition |
Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. |
heart left ventricle mass |
male |
168 days
| 4 |
|
2.84 |
mg/g |
0.18 |
0.36 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
103114 |
2786 |
SD |
heart left ventricle weight to body weight ratio |
left anterior descending coronary artery occlusion (for 28 days) |
Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. |
heart left ventricle mass |
male |
77 days
| 6 |
|
1.67 |
mg/g |
0.04 |
0.1 |
ex vivo method |
|
0.0 |
lad occlusion |
28 |
days |
|
|
101095 |
2564 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
11 |
|
3.08 |
mg/g |
0.06 |
0.2 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107035 |
3073 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (1 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
10 |
|
2.82 |
mg/g |
0.07 |
0.22 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107037 |
3073 |
SHRSP/A3NCrl |
heart left ventricle weight to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
heart left ventricle mass |
male |
134 days-141 days |
10 |
|
2.85 |
mg/g |
0.1 |
0.32 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
3-5 cardiac cycles |
LV mass calculated from 2-D images with area-length method |
107039 |
3073 |
MWF-Chr 8SHR/Rkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168 days
| 10 |
|
2.0 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108942 |
3133 |
MWF-Chr 8SHR/Rkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168 days
| 10 |
|
2.49 |
mg/g |
0.05 |
0.16 |
post excision weight measurement |
heart left ventricle |
0.0 |
|
0 |
|
|
|
108943 |
3133 |
SS.LEW-(D10Rat24-Igfbp4)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
3.2 |
mg/g |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64920 |
226 |
WKY/N |
heart left ventricle weight to body weight ratio |
control condition |
Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. |
heart left ventricle mass |
female |
84 days
| 22 |
|
1.68 |
mg/g |
0.14 |
0.66 |
post excision weight measurement |
|
|
|
0 |
|
|
|
13074 |
327 |
SS.LEW-(D18Chm56-D18Rat55)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
3.2 |
mg/g |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64894 |
226 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 4 |
|
3.03 |
mg/g |
0.09 |
0.18 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
64946 |
226 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
|
3.7 |
mg/g |
0.07 |
0.3 |
post excision weight measurement |
|
0.0 |
|
0 |
|
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68337 |
101 |
LEW |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 14 |
|
2.42 |
mg/g |
0.14 |
0.54 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
68257 |
542 |
LH/Mav |
heart left ventricle weight to body weight ratio |
controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
heart left ventricle mass |
male |
119 days
| 7 |
|
2.79 |
mg/g |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
103413 |
2824 |
SD |
heart left ventricle weight to body weight ratio |
sham surgical control condition (for 2 days) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart left ventricle mass |
male |
0 days
| 6 |
g/g*103 |
2.2 |
mg/g |
0.1 |
0.24 |
post excision weight measurement |
|
1.0 |
sham ACF |
2 |
days |
|
|
98790 |
2160 |